35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cannabis Addiction and the Brain: a Review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cannabis is the most commonly used substance of abuse in the United States after alcohol and tobacco. With a recent increase in the rates of cannabis use disorder (CUD) and a decrease in the perceived risk of cannabis use, it is imperative to assess the addictive potential of cannabis. Here we evaluate cannabis use through the neurobiological model of addiction proposed by Koob and Volkow. The model proposes that repeated substance abuse drives neurobiological changes in the brain that can be separated into three distinct stages, each of which perpetuates the cycle of addiction. Here we review previous research on the acute and long-term effects of cannabis use on the brain and behavior, and find that the three-stage framework of addiction applies to CUD in a manner similar to other drugs of abuse, albeit with some slight differences. These findings highlight the urgent need to conduct research that elucidates specific neurobiological changes associated with CUD in humans.

          Related collections

          Most cited references122

          • Record: found
          • Abstract: found
          • Article: not found

          Neurobiology of addiction: a neurocircuitry analysis.

          Drug addiction represents a dramatic dysregulation of motivational circuits that is caused by a combination of exaggerated incentive salience and habit formation, reward deficits and stress surfeits, and compromised executive function in three stages. The rewarding effects of drugs of abuse, development of incentive salience, and development of drug-seeking habits in the binge/intoxication stage involve changes in dopamine and opioid peptides in the basal ganglia. The increases in negative emotional states and dysphoric and stress-like responses in the withdrawal/negative affect stage involve decreases in the function of the dopamine component of the reward system and recruitment of brain stress neurotransmitters, such as corticotropin-releasing factor and dynorphin, in the neurocircuitry of the extended amygdala. The craving and deficits in executive function in the so-called preoccupation/anticipation stage involve the dysregulation of key afferent projections from the prefrontal cortex and insula, including glutamate, to the basal ganglia and extended amygdala. Molecular genetic studies have identified transduction and transcription factors that act in neurocircuitry associated with the development and maintenance of addiction that might mediate initial vulnerability, maintenance, and relapse associated with addiction.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adverse Health Effects of Marijuana Use

            New England Journal of Medicine, 370(23), 2219-2227
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The conception of the ABCD study: From substance use to a broad NIH collaboration

              Adolescence is a time of dramatic changes in brain structure and function, and the adolescent brain is highly susceptible to being altered by experiences like substance use. However, there is much we have yet to learn about how these experiences influence brain development, how they promote or interfere with later health outcomes, or even what healthy brain development looks like. A large longitudinal study beginning in early adolescence could help us understand the normal variability in adolescent brain and cognitive development and tease apart the many factors that influence it. Recent advances in neuroimaging, informatics, and genetics technologies have made it feasible to conduct a study of sufficient size and scope to answer many outstanding questions. At the same time, several Institutes across the NIH recognized the value of collaborating in such a project because of its ability to address the role of biological, environmental, and behavioral factors like gender, pubertal hormones, sports participation, and social/economic disparities on brain development as well as their association with the emergence and progression of substance use and mental illness including suicide risk. Thus, the Adolescent Brain Cognitive Development study was created to answer the most pressing public health questions of our day.
                Bookmark

                Author and article information

                Contributors
                gene-jack.wang@nih.gov
                Journal
                J Neuroimmune Pharmacol
                J Neuroimmune Pharmacol
                Journal of Neuroimmune Pharmacology
                Springer US (New York )
                1557-1890
                1557-1904
                19 March 2018
                19 March 2018
                2018
                : 13
                : 4
                : 438-452
                Affiliations
                [1 ]ISNI 0000 0004 0481 4802, GRID grid.420085.b, Laboratory of Neuroimaging, , National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, ; 10 Center Drive 31, Room B2L124, Bethesda, MD 20892 USA
                [2 ]ISNI 0000 0004 0533 7147, GRID grid.420090.f, National Institute on Drug Abuse, National Institutes of Health, ; Bethesda, MD 20892 USA
                Author information
                http://orcid.org/0000-0002-5017-9905
                Article
                9782
                10.1007/s11481-018-9782-9
                6223748
                29556883
                7926473c-9304-434f-b9f4-d3f8618c9478
                © The Author(s) 2018

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 18 January 2018
                : 7 March 2018
                Funding
                Funded by: NIH Intramural Program
                Award ID: YIAA3009
                Categories
                Invited Review
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2018

                Pharmacology & Pharmaceutical medicine
                substance use disorders,dopamine,marijuana,thc
                Pharmacology & Pharmaceutical medicine
                substance use disorders, dopamine, marijuana, thc

                Comments

                Comment on this article